Logical reasoning PrepTest 148 · Section 3 · Question 17
Question prompt
Why the credited answer is right
Credited answer: B
The notes below walk through why it fits the stem and how to eliminate the rest.
Question Type
Answer choices
-
AThe government health service Remaining source text redacted.
Why choice A is not credited
Incorrect. The GHS states that they won't pay for Antinfia until its cost effectiveness is proven, but that doesn't establish that this is a general rule they apply to all medications. Maybe it just applies to flu meds! -
BAntinfia will never be Remaining source text redacted.
Why choice B matches the stem
Correct. Argument or Facts:
Facts
Question Type:
Must Be True
Stimulus Summary:
Government health services: We won't pay for Antinfia until you prove its cost effectiveness.
PharmCo: We can't prove its cost effectiveness until you pay for Antinfia.
Answer Anticipation:
The Government Health Services' position is that proving cost effectiveness is necessary to them paying for it. PharmCo's position is that the GHS paying for it is necessary to them proving cost effectiveness. In short, both sides need the action of the other to happen before they can do their action. Since there's no way for that to happen, we must accept that Antinfia is destined to not be implemented by the GHS.
Answer Explanation:
This answer highlights that the GHS won't pay for Antinfia until its cost effectiveness is proven, which can't happen until the GHS pays for it and it's in widespread circulation. Since a necessary condition for Antinfia going into widespread circulation requires that it's already in widespread circulation, it will never be able to go into that circulation.
Key Takeaway:
When it's necessary for two separate actions to happen first before the other can happen, then those two actions can't happen. It's rare that the LSAT sets up a situation where something is impossible, but this is one of the places where that happens. -
CIf the government health Remaining source text redacted.
Why choice C is not credited
Incorrect. There's no discussion of patients or their paying out of pocket for meds, so this answer is out of scope. -
DThe government health service Remaining source text redacted.
Why choice D is not credited
Incorrect. There are no statements of opinion or what "should" happen in the stimulus, so this answer including that language is out of scope. -
EAntinfia is not cost-effective.
Why choice E is not credited
Incorrect. The cost effectiveness hasn't been studied and can't be until it's in widespread circulation, so we can't draw this conclusion.
What this tests
Question analytics
Based on historical answer selection rates for this question.
Answer choice distribution
Accounts
Save your place across PrepTests
Bookmark questions, build weak-spot lists, and pick up exactly where you left off—built for serious repeat practice.
No payment yet. We will only email when accounts open.
Already have an account? Log in
Deeper help
Ask follow-ups on any step
Optional AI tutor mode will let you interrogate assumptions, compare answers, and drill weak patterns without leaving the page.
Human-written explanations stay primary; AI is an add-on when you want it.
Discussion
-
Why not E? 1 reply
Started by farnoushsalimian